A nomogram based on inflammation and nutritional biomarkers for predicting the survival of breast cancer patients
- Caibiao Wei 1, Huaying Ai 2, Dan Mo 3, Peidong Wang 1, Liling Wei 4, Zhimin Liu 1, Peizhang Li 1, Taijun Huang 1, Miaofeng Liu 1
- Caibiao Wei 1, Huaying Ai 2, Dan Mo 3
- 1Department of Clinical Laboratory, Guangxi Medical University Cancer Hospital, Nanning, China.
- 2Department of Injection Room, The People's Hospital of Yingtan, Yingtan, Jiangxi, China.
- 3Department of Breast, Guangxi Zhuang Autonomous Region Maternal and Child Health Care Hospital, Nanning, China.
- 4Department of Anesthesiology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- 0Department of Clinical Laboratory, Guangxi Medical University Cancer Hospital, Nanning, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new prognostic model integrating inflammation, nutrition, and clinical data accurately predicts breast cancer survival. This tool enhances personalized treatment strategies for breast cancer (BC) patients.
Area Of Science
- Oncology
- Biostatistics
Background
- Breast cancer (BC) prognosis requires improved predictive models.
- Current models may not fully integrate inflammatory and nutritional markers.
Purpose Of The Study
- To develop and validate a novel prognostic nomogram for breast cancer (BC).
- To incorporate inflammation, nutritional parameters, and clinicopathological features for predicting overall survival (OS) and disease-free survival (DFS).
Main Methods
- Utilized data from 2857 BC patients (2013-2021), divided into training (n=2001) and validation (n=856) cohorts.
- Developed a nomogram using multivariate Cox regression analysis.
- Evaluated predictive accuracy and discrimination using concordance index (C-index) and calibration curves.
- Assessed clinical utility via decision curve analysis (DCA).
Main Results
- The developed nomogram incorporates lymphocyte count, platelet count, hemoglobin, albumin-to-globulin ratio, prealbumin, subtype, and TNM staging.
- The nomogram demonstrated a statistically superior C-index for predicting OS and DFS compared to TNM staging alone.
- Time-dependent AUC exceeded 0.7, indicating satisfactory discriminative performance.
- DCA showed greater overall net benefit for the nomogram compared to TNM staging.
Conclusions
- The nomogram integrating inflammation, nutritional, and clinicopathological variables shows excellent discrimination.
- This tool is promising for predicting BC patient outcomes.
- It can aid in defining personalized treatment strategies for breast cancer.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

